silodosin recordati
recordati ireland ltd - silodosin - prostatisk hyperplasi - urologicals, alfa-antagonister adrenoreceptor - behandling av tegn og symptomer på godartet prostatahyperplasi (bph) hos voksne menn.
bloxazoc 25 mg
krka, d.d. novo mesto - metoprololsuksinat - depottablett - 25 mg
bloxazoc 50 mg
krka, d.d. novo mesto - metoprololsuksinat - depottablett - 50 mg
bloxazoc 100 mg
krka, d.d. novo mesto - metoprololsuksinat - depottablett - 100 mg
hepcludex
gilead sciences ireland uc - bulevirtide acetate - hepatitis d, chronic - antivirale midler til systemisk bruk - hepcludex is indicated for the treatment of chronic hepatitis delta virus (hdv) infection in plasma (or serum) hdv-rna positive adult patients with compensated liver disease.
bloxazoc 200 mg
krka, d.d. novo mesto - metoprololsuksinat - depottablett - 200 mg
aqumeldi
proveca pharma limited - enalapril (maleate) - hjertefeil - agenter som virker på renin-angiotensinsystemet - treatment of heart failure.
zavicefta
pfizer ireland pharmaceuticals - avibactam sodium, ceftazidime pentahydrate - pneumonia, bacterial; soft tissue infections; pneumonia; urinary tract infections; gram-negative bacterial infections - antibakterielle midler for systemisk bruk, - zavicefta is indicated in adults and paediatric patients aged 3 months and older for the treatment of the following infections:complicated intra-abdominal infection (ciai)complicated urinary tract infection (cuti), including pyelonephritishospital-acquired pneumonia (hap), including ventilator associated pneumonia (vap)treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above. zavicefta is also indicated for the treatment of infections due to aerobic gram-negative organisms in adults and paediatric patients aged 3 months and older with limited treatment options. det bør vurderes å offisielle retningslinjer for riktig bruk av antibakterielle midler.
zinforo
pfizer ireland pharmaceuticals - ceftaroline fosamil - community-acquired infections; skin diseases, infectious; pneumonia - antibakterielle midler for systemisk bruk, - zinforo is indicated for the treatment of the following infections in neonates, infants, children, adolescents and adults: , complicated skin and soft tissue infections (cssti), community-acquired pneumonia (cap) , consideration should be given to official guidance on the appropriate use of antibacterial agents.
celebra 100 mg
upjohn eesv - celekoksib - kapsel, hard - 100 mg